Jan 2013 to Dec 2017 | Jan 2017 to Dec 2017
CHARGE CAPTURE ANALYSIS FOR DRG 848: CHEMOTHERAPY WITHOUT ACUTE LEUKEMIA AS SECONDARY DIAGNOSIS WITHOUT COMPLICATION OR COMORBIDITY (CC)/MAJOR COMPLICATION OR COMORBIDITY (MCC) GROUP BASED ON MEDICARE | Back to Top |
| DRG Code | DRG Description | Category | Sub Category | DRG Group | Surgical Category | Case Mix Level | Total National Projected Hospitalizations - Annualized | Total Medicare Hospitalizations - Jan 2017 to Dec 2017 | Total Medicare Hospitalizations - Jan 2013 to Dec 2017 | Total Medicare Hospitalizations After Exclusion | Avg. LOS | GMLOS | All Cause Readmission Rate (%) | Unplanned Readmission Rate (%) | Total Medicare Payments | Payment per Day | Payment per Discharge | Total Medicare Charges | Avg. Charges | Mortality Rate (%) | SNF Discharge Rate (%) | Home Discharge Rate (%) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 848 | CHEMOTHERAPY WITHOUT ACUTE LEUKEMIA AS SECONDARY DIAGNOSIS WITHOUT COMPLICATION OR COMORBIDITY (CC)/MAJOR COMPLICATION OR COMORBIDITY (MCC) | Oncology & Hematology | Chemotherapy Without Acute Leukemia As Secondary Diagnosis | Chemotherapy Without Acute Leukemia As Secondary Diagnosis | Non Surgical | 2.80 | NA | 378 | 2,814 | 2,806 | ||||||||||||
| 846 | CHEMOTHERAPY WITHOUT ACUTE LEUKEMIA AS SECONDARY DIAGNOSIS WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | Oncology & Hematology | Chemotherapy Without Acute Leukemia As Secondary Diagnosis | Chemotherapy Without Acute Leukemia As Secondary Diagnosis | Non Surgical | 17.00 | NA | 3,899 | 17,084 | 16,264 | ||||||||||||
| 847 | CHEMOTHERAPY WITHOUT ACUTE LEUKEMIA AS SECONDARY DIAGNOSIS WITH COMPLICATION OR COMORBIDITY (CC) | Oncology & Hematology | Chemotherapy Without Acute Leukemia As Secondary Diagnosis | Chemotherapy Without Acute Leukemia As Secondary Diagnosis | Non Surgical | 80.20 | NA | 15,246 | 80,577 | 80,313 |
DEMOGRAPHIC DETAILS OF DRG 848: CHEMOTHERAPY WITHOUT ACUTE LEUKEMIA AS SECONDARY DIAGNOSIS WITHOUT COMPLICATION OR COMORBIDITY (CC)/MAJOR COMPLICATION OR COMORBIDITY (MCC) | Back to Top |
| Race | Total Hospitalization Volume - Jan 2013 to Dec 2017 | % of DRG Volume |
|---|---|---|
| White | 2,081 | 73.95 |
| Black | 458 | 16.28 |
| Hispanic | 83 | 2.95 |
| Age Group ( Years ) | Total Hospitalization Volume - Jan 2013 to Dec 2017 | % of DRG Volume |
|---|---|---|
| 65 to 69 | 944 | 33.55 |
| 70 to 74 | 665 | 23.63 |
| Less than 65 | 569 | 20.22 |
TOP ICD DIAGNOSIS CODES FOR DRG 848: CHEMOTHERAPY WITHOUT ACUTE LEUKEMIA AS SECONDARY DIAGNOSIS WITHOUT COMPLICATION OR COMORBIDITY (CC)/MAJOR COMPLICATION OR COMORBIDITY (MCC) | Back to Top |
| ICD Code | ICD Description | Total ICD & DRG Hospitalization Volume - Jan 2013 to Dec 2017 | % of DRG Volume |
|---|---|---|---|
| V5811 | Encounter for antineoplastic chemotherapy | 1,753 | 62.3 |
| Z5111 | Encounter for antineoplastic chemotherapy | 1,024 | 36.39 |
| 4019 | Unspecified essential hypertension | 893 | 31.73 |
TOP ICD PROCEDURE CODES FOR DRG 848: CHEMOTHERAPY WITHOUT ACUTE LEUKEMIA AS SECONDARY DIAGNOSIS WITHOUT COMPLICATION OR COMORBIDITY (CC)/MAJOR COMPLICATION OR COMORBIDITY (MCC) | Back to Top |
| ICD Code | ICD Description | Total Procedure ICD & DRG Hospitalization Volume - Jan 2013 to Dec 2017 | % of DRG Volume |
|---|---|---|---|
| 9925 | Injection Or Infusion Of Cancer Chemotherapeutic Substance | 1,664 | 59.13 |
| 3E03305 | Introduction of Other Antineoplastic into Peripheral Vein, Percutaneous Approach | 436 | 15.49 |
| 3E04305 | Introduction of Other Antineoplastic into Central Vein, Percutaneous Approach | 416 | 14.78 |
TOP HOSPITALS ASSOCIATED WITH DRG 848: CHEMOTHERAPY WITHOUT ACUTE LEUKEMIA AS SECONDARY DIAGNOSIS WITHOUT COMPLICATION OR COMORBIDITY (CC)/MAJOR COMPLICATION OR COMORBIDITY (MCC) | Back to Top |
| Hospital Name | Address | City | State | Zip Code | Total Hospital & DRG Hospitalization Volume - Jan 2013 to Dec 2017 | % of DRG Volume |
|---|---|---|---|---|---|---|
| University of Texas MD Anderson Cancer Center | 1515 HOLCOMBE BLVD | Houston | TX | 77030 | 333 | 11.83 |
| University of Miami Hospital | 1475 NW 12TH AVE | Miami | FL | 33136 | 55 | 1.95 |
| The University of Mississippi Medical Center | 2500 N STATE ST | Jackson | MS | 39216 | 40 | 1.42 |
TOP ATTENDING PHYSICIAN ASSOCIATED WITH DRG 848: CHEMOTHERAPY WITHOUT ACUTE LEUKEMIA AS SECONDARY DIAGNOSIS WITHOUT COMPLICATION OR COMORBIDITY (CC)/MAJOR COMPLICATION OR COMORBIDITY (MCC) | Back to Top |
| Physician Name | Address | City | State | Zip Code | Total Physician & DRG Hospitalization Volume - Jan 2013 to Dec 2017 | % of DRG Volume |
|---|---|---|---|---|---|---|
| DR. ARLENE O. SIEFKER-RADTKE | 1515 HOLCOMBE BLVD | HOUSTON | TX | 77030 | 32 | 1.14 |
| DR. JERI KIM | 1515 HOLCOMBE BLVD | HOUSTON | TX | 77030 | 26 | 0.92 |
| DR. ROBERT S ALTER | 92 2ND ST | HACKENSACK | NJ | 07601 | 26 | 0.92 |
TOP OPERATING PHYSICIAN ASSOCIATED WITH DRG 848: CHEMOTHERAPY WITHOUT ACUTE LEUKEMIA AS SECONDARY DIAGNOSIS WITHOUT COMPLICATION OR COMORBIDITY (CC)/MAJOR COMPLICATION OR COMORBIDITY (MCC) | Back to Top |
| Physician Name | Address | City | State | Zip Code | Total Physician & DRG Hospitalization Volume - Jan 2013 to Dec 2017 | % of DRG Volume |
|---|---|---|---|---|---|---|
| DR. ARLENE O. SIEFKER-RADTKE | 1515 HOLCOMBE BLVD | HOUSTON | TX | 77030 | 58 | 2.06 |
| DR. MATTHEW T CAMPBELL | 1515 HOLCOMBE BLVD | HOUSTON | TX | 77030 | 28 | 1.0 |
| DR. PAUL G. CORN | 1515 HOLCOMBE BLVD | HOUSTON | TX | 77030 | 28 | 1.0 |
DRG 848: CHEMOTHERAPY WITHOUT ACUTE LEUKEMIA AS SECONDARY DIAGNOSIS WITHOUT COMPLICATION OR COMORBIDITY (CC)/MAJOR COMPLICATION OR COMORBIDITY (MCC) SUMMARY TABLE | Back to Top |
| Category | Sub Category | DRG Group | ICD Codes | ICD Description | National Projected Hospitalizations (Present on Admission - All) Jan 2016 to Dec 2016 | Medicare Hospitalizations (Present on Admission - All) Jan 2013 to Dec 2017 | National Projected Hospitalizations(Present on Admission - Yes) Jan 2016 to Dec 2016 | Medicare Hospitalizations (Present on Admission - Yes) Jan 2013 to Dec 2017 | National Projected Hospitalizations (Present on Admission - Not Y) Jan 2016 to Dec 2016 | Medicare Hospitalizations (Present on Admission - Not Y) Jan 2013 to Dec 2017 | Total Discharges After Exclusion | Avg. LOS | GMLOS | All Cause Readmission Rate (%) | Unplanned Readmission Rate (%) | Total Medicare Payments | Payment per Day | Payment per Discharge | Total Medicare Charges | Avg. Charges | Mortality Rate (%) | SNF Discharge Rate (%) | Home Discharge Rate (%) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Oncology & Hematology | Chemotherapy Without Acute Leukemia As Secondary Diagnosis | Chemotherapy Without Acute Leukemia As Secondary Diagnosis | V5811 | Encounter for antineoplastic chemotherapy | NA | 1,753 | |||||||||||||||||
| Oncology & Hematology | Chemotherapy Without Acute Leukemia As Secondary Diagnosis | Chemotherapy Without Acute Leukemia As Secondary Diagnosis | Z5111 | Encounter for antineoplastic chemotherapy | 6,060 | 1,024 | |||||||||||||||||
| Oncology & Hematology | Chemotherapy Without Acute Leukemia As Secondary Diagnosis | Chemotherapy Without Acute Leukemia As Secondary Diagnosis | 4019 | Unspecified essential hypertension | NA | 893 | |||||||||||||||||
| Oncology & Hematology | Chemotherapy Without Acute Leukemia As Secondary Diagnosis | Chemotherapy Without Acute Leukemia As Secondary Diagnosis | I10 | Essential (primary) hypertension | 1,156 | 542 | |||||||||||||||||
| Oncology & Hematology | Chemotherapy Without Acute Leukemia As Secondary Diagnosis | Chemotherapy Without Acute Leukemia As Secondary Diagnosis | 2724 | Other and unspecified hyperlipidemia | NA | 392 | |||||||||||||||||
| Oncology & Hematology | Chemotherapy Without Acute Leukemia As Secondary Diagnosis | Chemotherapy Without Acute Leukemia As Secondary Diagnosis | E785 | Hyperlipidemia, unspecified | 365 | 327 | |||||||||||||||||
| Oncology & Hematology | Chemotherapy Without Acute Leukemia As Secondary Diagnosis | Chemotherapy Without Acute Leukemia As Secondary Diagnosis | V1582 | Personal history of tobacco use | NA | 308 | |||||||||||||||||
| Oncology & Hematology | Chemotherapy Without Acute Leukemia As Secondary Diagnosis | Chemotherapy Without Acute Leukemia As Secondary Diagnosis | 25000 | Diabetes mellitus without mention of complication, type II or unspecified type, not stated as uncontrolled | NA | 306 | |||||||||||||||||
| Oncology & Hematology | Chemotherapy Without Acute Leukemia As Secondary Diagnosis | Chemotherapy Without Acute Leukemia As Secondary Diagnosis | V5869 | Long-term (current) use of other medications | NA | 286 | |||||||||||||||||
| Oncology & Hematology | Chemotherapy Without Acute Leukemia As Secondary Diagnosis | Chemotherapy Without Acute Leukemia As Secondary Diagnosis | Z87891 | Personal history of nicotine dependence | 616 | 271 |